169 related articles for article (PubMed ID: 24081207)
1. Population pharmacokinetic analysis of tacrolimus early after pediatric liver transplantation.
Musuamba FT; Guy-Viterbo V; Reding R; Verbeeck RK; Wallemacq P
Ther Drug Monit; 2014 Feb; 36(1):54-61. PubMed ID: 24081207
[TBL] [Abstract][Full Text] [Related]
2. A simultaneous d-optimal designed study for population pharmacokinetic analyses of mycophenolic Acid and tacrolimus early after renal transplantation.
Musuamba FT; Mourad M; Haufroid V; Demeyer M; Capron A; Delattre IK; Delaruelle F; Wallemacq P; Verbeeck RK
J Clin Pharmacol; 2012 Dec; 52(12):1833-43. PubMed ID: 22207766
[TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetics of tacrolimus in pediatric liver transplantation: early posttransplantation clearance.
Wallin JE; Bergstrand M; Wilczek HE; Nydert PS; Karlsson MO; Staatz CE
Ther Drug Monit; 2011 Dec; 33(6):663-72. PubMed ID: 22105583
[TBL] [Abstract][Full Text] [Related]
4. Population pharmacokinetic analysis of tacrolimus in the first year after pediatric liver transplantation.
Guy-Viterbo V; Scohy A; Verbeeck RK; Reding R; Wallemacq P; Musuamba FT
Eur J Clin Pharmacol; 2013 Aug; 69(8):1533-42. PubMed ID: 23588560
[TBL] [Abstract][Full Text] [Related]
5. Tacrolimus dose individualization in "de novo" patients after 10 years of experience in liver transplantation: pharmacokinetic considerations and patient pathophysiology.
Valdivieso N; Oteo I; Valdivieso A; Lukas JC; Leal N; Gastaca M; de Urbina JO; Calvo R; Suarez E
Int J Clin Pharmacol Ther; 2013 Jul; 51(7):606-14. PubMed ID: 23735178
[TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetic analysis of tacrolimus early after Chinese pediatric liver transplantation.
Yang JW; Liao SS; Zhu LQ; Zhao Y; Zhang Y; Sun XY; Rao W; Qu W; Li WZ; Sun LY
Int J Clin Pharmacol Ther; 2015 Jan; 53(1):75-83. PubMed ID: 25207550
[TBL] [Abstract][Full Text] [Related]
7. The impact of sulfonylureas on tacrolimus apparent clearance revealed by a population pharmacokinetics analysis in Chinese adult liver-transplant patients.
Zhang XQ; Wang ZW; Fan JW; Li YP; Jiao Z; Gao JW; Peng ZH; Liu GL
Ther Drug Monit; 2012 Apr; 34(2):126-33. PubMed ID: 22377746
[TBL] [Abstract][Full Text] [Related]
8. Time of drug administration, CYP3A5 and ABCB1 genotypes, and analytical method influence tacrolimus pharmacokinetics: a population pharmacokinetic study.
Musuamba FT; Mourad M; Haufroid V; Delattre IK; Verbeeck RK; Wallemacq P
Ther Drug Monit; 2009 Dec; 31(6):734-42. PubMed ID: 19855314
[TBL] [Abstract][Full Text] [Related]
9. Comparison of two population pharmacokinetic programs, NONMEM and P-PHARM, for tacrolimus.
Staatz CE; Tett SE
Eur J Clin Pharmacol; 2002 Dec; 58(9):597-605. PubMed ID: 12483452
[TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetic estimation of tacrolimus apparent clearance in adult liver transplant recipients.
Zahir H; McLachlan AJ; Nelson A; McCaughan G; Gleeson M; Akhlaghi F
Ther Drug Monit; 2005 Aug; 27(4):422-30. PubMed ID: 16044097
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetic-pharmacogenetic model of tacrolimus in the early period after kidney transplantation.
Han N; Ha S; Yun HY; Kim MG; Min SI; Ha J; Lee JI; Oh JM; Kim IW
Basic Clin Pharmacol Toxicol; 2014 May; 114(5):400-6. PubMed ID: 24238261
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetics of tacrolimus in adult kidney transplant recipients.
Staatz CE; Willis C; Taylor PJ; Tett SE
Clin Pharmacol Ther; 2002 Dec; 72(6):660-9. PubMed ID: 12496747
[TBL] [Abstract][Full Text] [Related]
13. Tacrolimus exposure and mycophenolate pharmacokinetics and pharmacodynamics early after liver transplantation.
Sæves I; Line PD; Bremer S; Vethe NT; Tveit RG; Meltevik TJ; Bergan S
Ther Drug Monit; 2014 Feb; 36(1):46-53. PubMed ID: 24081206
[TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetics of tacrolimus in whole blood and plasma in asian liver transplant patients.
Sam WJ; Tham LS; Holmes MJ; Aw M; Quak SH; Lee KH; Lim SG; Prabhakaran K; Chan SY; Ho PC
Clin Pharmacokinet; 2006; 45(1):59-75. PubMed ID: 16430311
[TBL] [Abstract][Full Text] [Related]
15. Influence of donor-recipient CYP3A4/5 genotypes, age and fluconazole on tacrolimus pharmacokinetics in pediatric liver transplantation: a population approach.
Guy-Viterbo V; Baudet H; Elens L; Haufroid V; Lacaille F; Girard M; Debray D; Chardot C; Reding R; Wallemacq P; Musuamba F
Pharmacogenomics; 2014 Jun; 15(9):1207-21. PubMed ID: 25141896
[TBL] [Abstract][Full Text] [Related]
16. Lessons from routine dose adjustment of tacrolimus in renal transplant patients based on global exposure.
Saint-Marcoux F; Woillard JB; Jurado C; Marquet P
Ther Drug Monit; 2013 Jun; 35(3):322-7. PubMed ID: 23666572
[TBL] [Abstract][Full Text] [Related]
17. Tacrolimus pharmacokinetics in Hispanic children after kidney transplantation.
Cherala G; Munar MY; Naher A; Al-Uzri A
Transplant Proc; 2011 Dec; 43(10):3708-12. PubMed ID: 22172831
[TBL] [Abstract][Full Text] [Related]
18. Toward better outcomes with tacrolimus therapy: population pharmacokinetics and individualized dosage prediction in adult liver transplantation.
Staatz CE; Willis C; Taylor PJ; Lynch SV; Tett SE
Liver Transpl; 2003 Feb; 9(2):130-7. PubMed ID: 12548506
[TBL] [Abstract][Full Text] [Related]
19. Circadian and time-dependent variability in tacrolimus pharmacokinetics.
Park SI; Felipe CR; Pinheiro-Machado PG; Garcia R; Tedesco-Silva H; Medina-Pestana JO
Fundam Clin Pharmacol; 2007 Apr; 21(2):191-7. PubMed ID: 17391292
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics and pharmacogenetics of tacrolimus in de novo pediatric kidney transplant recipients.
Zhao W; Elie V; Roussey G; Brochard K; Niaudet P; Leroy V; Loirat C; Cochat P; Cloarec S; André JL; Garaix F; Bensman A; Fakhoury M; Jacqz-Aigrain E
Clin Pharmacol Ther; 2009 Dec; 86(6):609-18. PubMed ID: 19865079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
